P2.11-03 Implementing Physician Education to Increase Lung Cancer Screening Compliance

Olazagasti, Coral; Rothman, Adam; Sampat, Devi; Chow, Dorothy K.; Seetharamu, Nagashree; Steiger, David

doi:10.1016/j.jtho.2019.08.1703

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…16 An educational initiative targeting PCPs and resident physicians involving PowerPoint presentations at various settings yielded a notable positive change, with follow-up analysis performed after the educational program showing an improved screening adherence from 27% to 78% (P < .0001) and a decrease in referral rates for patients that did not meet criteria for screening. 17 Concerning findings suggesting lack of physician knowledge about screening eligibility that extrapolated from our study are the use of the wrong screening modality in eligible individuals as well as LDCT implementations in ineligible individuals. One study found that 8.5% of eligible patients underwent a CXR for screening compared to 4.4% that had LDCT.…”

Section: Discussionmentioning

confidence: 75%

Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer

et al. 2022

View full text Add to dashboard Cite

Lung cancer (LC) is the leading cause of cancer-related deaths worldwide. The U.S. Preventive Services Task Force (USPSTF) and National Comprehensive Cancer Network (NCCN) recommend annual low-dose CT chest (LDCT) for LC screening in high-risk adults who meet appropriate criteria, which primarily focus on age and smoking history. Despite this, screening rates remain low and patients with LC are typically diagnosed at a later stage. We conducted a single-center retrospective analysis of patients with an established diagnosis of lung cancer to evaluate if screening guidelines were appropriately followed before the cancer diagnosis. Patients diagnosed with LC between 2016 and 2019 were included in the analysis. Charts were reviewed for demographics, detailed smoking history, as well as histology and stage of LC. Associations between categorical factors and screening were examined using the chi-square test. Associations between continuous and ordinal factors and screening were examined using the Mann–Whitney test. A total of 530 charts were reviewed, of which 52% met NCCN criteria and 35% met USPSTF criteria. Only 4.0% and 4.8% of patients who met NCCN and USPSTF criteria, respectively, underwent screening. There was a significant association between staging at diagnosis and screening with LDCT. All the patients who had screening CT scans were diagnosed at localized stages of lung cancer in both NCCN and USPSTF groups compared to 49.1% and 48% in eligible subjects that did not undergo screening, respectively. Our study showed that despite established guidelines for LC screening and insurance coverage, a vast majority of screening-eligible LC patients have never had LDCT. We found that patients who underwent screening as per guidelines were diagnosed at earlier stages of the disease. Ongoing efforts to increase awareness and adherence to LC screening guidelines are needed to improve early detection and reduce LC mortality.

show abstract

Section: Discussionmentioning

confidence: 75%